Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T81183 | Target Info | |||
Target Name | Adrenergic receptor Alpha-1 (ADRA1) | ||||
Synonyms |
Alpha1-adrenoceptor; Alpha(1)-adrenoceptor
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | NO-GeName | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | 5-HT 1D receptor (HTR1D) | Successful Target | ||||
UniProt ID | 5HT1D_HUMAN | |||||
Gene Name | HTR1D | |||||
Synonyms |
Serotonin receptor 1D; Serotonin 1D alpha receptor; HTRL; HTR1DA; 5HT1D; 5-hydroxytryptamine receptor 1D; 5-HT1D receptor; 5-HT1D; 5-HT-1D-alpha; 5-HT-1D
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | Ki = 0.33 nM | Click to Show More | [1] | |
2 | Ergotamine | Drug Info | Ki = 0.8 nM | [2] | ||
Co-Target Name | 5-HT 1B receptor (HTR1B) | Successful Target | ||||
UniProt ID | 5HT1B_HUMAN | |||||
Gene Name | HTR1B | |||||
Synonyms |
Serotonin receptor 1B; Serotonin 1D beta receptor; S12; HTR1DB; 5-hydroxytryptamine receptor 1B; 5-HT1B receptor; 5-HT1B; 5-HT-1D-beta; 5-HT-1B
Click to Show/Hide
|
|||||
Representative Drug(s) | Ergotamine | Drug Info | Ki = 2.1 nM | [3] | ||
Co-Target Name | Quinone reductase 2 (NQO2) | Successful Target | ||||
UniProt ID | NQO2_HUMAN | |||||
Gene Name | NQO2 | |||||
Synonyms |
Quinone oxidoreductase 2; Qui reductase 2; QR2; NRH:quinone oxidoreductase 2; NRH:qui oxidoreductase 2; NQO2; NAD(P)H qui oxidoreductase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | IC50 = 7.8 nM | [4] | ||
Co-Target Name | 5-HT 1A receptor (HTR1A) | Successful Target | ||||
UniProt ID | 5HT1A_HUMAN | |||||
Gene Name | HTR1A | |||||
Synonyms |
Serotonin receptor 1A; G-21; ADRBRL1; ADRB2RL1; 5-hydroxytryptamine receptor 1A; 5-HT1A receptor; 5-HT1A; 5-HT-1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | Ki ~ 10 nM | Click to Show More | [5] | |
2 | Urapidil | Drug Info | Ki = 213 nM | [9] | ||
Co-Target Name | Adrenergic receptor alpha-2B (ADRA2B) | Successful Target | ||||
UniProt ID | ADA2B_HUMAN | |||||
Gene Name | ADRA2B | |||||
Synonyms |
Subtype C2; Alpha-2BAR; Alpha-2B adrenoreceptor; Alpha-2B adrenoceptor; Alpha-2B adrenergic receptor; Alpha-2 adrenergic receptor subtype C2; ADRA2RL1; ADRA2L1
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | Ki = 13 nM | [6] | ||
Co-Target Name | 5-HT 5A receptor (HTR5A) | Successful Target | ||||
UniProt ID | 5HT5A_HUMAN | |||||
Gene Name | HTR5A | |||||
Synonyms |
Serotonin receptor 5A; 5-hydroxytryptamine receptor 5A; 5-HT5A; 5-HT-5A; 5-HT-5; 5-HT 5A
Click to Show/Hide
|
|||||
Representative Drug(s) | Ergotamine | Drug Info | Ki = 14 nM | [7] | ||
Co-Target Name | Adrenergic receptor alpha-2C (ADRA2C) | Successful Target | ||||
UniProt ID | ADA2C_HUMAN | |||||
Gene Name | ADRA2C | |||||
Synonyms |
Subtype C4; Alpha-2CAR; Alpha-2C adrenoreceptor; Alpha-2C adrenoceptor; Alpha-2C adrenergic receptor; Alpha-2 adrenergic receptor subtype C4; ADRA2RL2; ADRA2L2
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | Ki = 24 nM | [6] | ||
Co-Target Name | Adrenergic receptor Alpha-2 (ADRA2) | Successful Target | ||||
UniProt ID | ADA2A_HUMAN; ADA2B_HUMAN; ADA2C_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
Alpha-2 adrenergic receptor; Alpha(2)-adrenoceptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | Ki = 34 nM | Click to Show More | [8] | |
2 | Prazosin | Drug Info | Ki = 34 nM | [8] | ||
Co-Target Name | Adrenergic receptor alpha-2A (ADRA2A) | Successful Target | ||||
UniProt ID | ADA2A_HUMAN | |||||
Gene Name | ADRA2A | |||||
Synonyms |
Alpha-2AAR; Alpha-2A adrenoreceptor; Alpha-2A adrenoceptor; Alpha-2A adrenergic receptor; Alpha-2 adrenergic receptor subtype C10; ADRAR; ADRA2R
Click to Show/Hide
|
|||||
Representative Drug(s) | Prazosin | Drug Info | Ki = 210 nM | [6] | ||
Co-Target Name | Voltage-gated potassium channel Kv11.1 (KCNH2) | Successful Target | ||||
UniProt ID | KCNH2_HUMAN | |||||
Gene Name | KCNH2 | |||||
Synonyms |
hERG1; hERG-1; Voltage-gated potassium channel subunit Kv11.1; Potassium voltage-gated channel subfamily H member 2; HERG K+ channel; HERG; H-ERG; Ether-a-go-go-related protein 1; Ether-a-go-go-related gene potassium channel 1; Ether-a-go-go related protein 1; Ether-a-go-go related gene potassium channel 1; Eag related protein 1; Eag homolog; ERG-1; ERG
Click to Show/Hide
|
|||||
Representative Drug(s) | Carvedilol | Drug Info | IC50 = 350 nM | [10] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia. J Med Chem. 1998 Dec 17;41(26):5320-33. | ||||
REF 2 | 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. J Med Chem. 2000 Mar 9;43(5):1011-8. | ||||
REF 3 | A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action. Bioorg Med Chem Lett. 2011 Nov 15;21(22):6714-23. | ||||
REF 4 | Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3. Eur J Med Chem. 2011 May;46(5):1622-9. | ||||
REF 5 | Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists. J Med Chem. 2001 Jul 19;44(15):2403-10. | ||||
REF 6 | Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine. J Med Chem. 1995 May 12;38(10):1579-81. | ||||
REF 7 | CNS and antimalarial activity of synthetic meridianin and psammopemmin analogs. Bioorg Med Chem. 2011 Oct 1;19(19):5756-62. | ||||
REF 8 | Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. J Med Chem. 1995 Sep 1;38(18):3415-44. | ||||
REF 9 | Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system. Bioorg Med Chem Lett. 2018 Jun 15;28(11):2039-2049. | ||||
REF 10 | The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4771-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.